NYSE: ALL · Financials · Insurance

The Allstate Corporation

Allstate is a US personal-lines property and casualty insurer selling auto, homeowners and other cover through exclusive agents, independent agencies and direct channels.

Our rating
Buy
12-month target
$309.41
Price, Nov 18, 2026
$266.59
Expected return, with dividend
+18%

Latest research: initiation, Nov 21, 2026Market value $66.3bn

ALLBuyTarget $309.41+18% expected

Our view, Nov 21, 2026

The price assumes a 96% combined ratio; we see 94% and 18% upside

Allstate is a top-four US personal-lines insurer, earning about $60 billion of premiums a year. At $266.59 the shares imply a 96.0% mid-cycle combined ratio and a 15.7% return on equity, against our 94.0% and 18.7%.

Where the price could be in 12 months
−$46.01 down+$126.76 upToday $266.59$220.58Bad case$329.12Middle case$393.35Good caseOur target $309.41

Circle size shows how likely we think each case is. Case values are 12-month values; the target weights all three and adds 12 months of expected return at a 9.21% cost of equity less a 1.62% dividend yield. Source: Penmark Research.

Read the full report

Our numbers against analysts’

Our FY26E earnings forecast is 7% above analysts’

For FY26E we forecast earnings per share of $40.63, against analysts’ $37.90. For FY27E we forecast earnings per share of $29.46, against analysts’ $27.58.

Our earnings per share forecasts against analysts’
$40.63$37.90FY26E$29.46$27.58FY27E$31.32FY28E
Our estimateAnalysts’ forecast

Earnings per share as the report gives them. Analysts’ forecast is the consensus figure in the report. Source: Penmark Research estimates.

How we value it

What would change our mind

What could prove us wrong

  • Auto loss-cost inflation repeating the 2022 trough (103.6% underlying auto ratio) drives the $205 bear case (30% probability).
  • A 1pp higher cost of equity cuts the weighted value to $256.24 and the target to $278.24, moving the rating to Hold (−$31 a share weighted).
  • Severe catastrophes lifting the homeowners catastrophe load toward the 38.6% FY23 level (−$2.5 a share) would erode underwriting earnings and pause buybacks.
What bears get right. A 1-point higher cost of equity cuts our target to $278.24, a Hold. A deeper auto loss-cost cycle that repeats 2022 drives the bad case, worth $205.02 a share today.
Dates to watch
  1. We expect $11.26 of earnings per share against about $8.49 implied by analysts, and a new buyback.

  2. Auto rate restarts should keep the auto underlying ratio at 93.0% or better.

  3. Shows whether the combined ratio holds near 92% to 94%, or slips toward the 96% priced in.

  4. We expect $29.46 of earnings per share, 6.8% above analysts’ $27.58.

Read the full report

Our research

Initiation28 pages

Initiate at Buy with a $309 target as margins normalise more slowly than priced

  • At $266.59 the stock implies a 96.0% normalised P-L combined ratio and 15.7% ROE, against our 94.0% and 18.7%; each 1pp is worth about $19.20 a share.
  • A 3.3pp structural expense cut, from 24.6% to 21.4%, and auto rate restarts across 39 locations cushion the auto margin give-back.
  • Reinvesting the $87.4bn portfolio toward 5.0% adds about $0.3bn of annual net investment income, while buybacks cut diluted shares 22% by FY30E.

Questions about The Allstate

Is The Allstate stock a buy, hold or sell?

Penmark Research rates The Allstate (ALL) Buy, with a 12-month price target of $309.41, +16% from the $266.59 share price at our latest report. We expect a total return of more than 10% over the next 12 months: the move to our price target, plus dividends.

What is the ALL price target?

Our 12-month price target for The Allstate is $309.41, set in our initiation of Nov 21, 2026. Our bear case values the shares at $220.58 and our bull case at $393.35. The target comes from the probability-weighted value of our bull, base and bear cases.

Will The Allstate stock go up?

Our The Allstate stock forecast is a 12-month price target of $309.41, +16% from the $266.59 share price at our latest report, which is why we rate it Buy. Our bear case puts the shares at $220.58 (-17%) and our bull case at $393.35 (+48%). No forecast is certain; the main risks are below.

What does The Allstate do?

Allstate is a US personal-lines property and casualty insurer selling auto, homeowners and other cover through exclusive agents, independent agencies and direct channels.

What are the main risks to The Allstate stock?

  • Auto loss-cost inflation repeating the 2022 trough (103.6% underlying auto ratio) drives the $205 bear case (30% probability).
  • A 1pp higher cost of equity cuts the weighted value to $256.24 and the target to $278.24, moving the rating to Hold (−$31 a share weighted).
  • Severe catastrophes lifting the homeowners catastrophe load toward the 38.6% FY23 level (−$2.5 a share) would erode underwriting earnings and pause buybacks.

What is Penmark’s latest research on The Allstate?

Our latest report is our initiation of Nov 21, 2026, “Initiate at Buy with a $309 target as margins normalise more slowly than priced”. We initiate on Allstate at Buy with a $309.41 target, a +17.8% total return from $266.59, with Low conviction. At today’s price the stock implies a 96.0% normalised Property-Liability combined ratio and a 15.7% ROE, against our 94.0% and 18.7%, helped by a 3.3pp structural expense cut. Our adjusted EPS sits 7.2%…

Sign in to Penmark